MedPath

Comparative evaluation of solifenacin and darifenacin for prevention of catheter related bladder discomfort

Phase 4
Completed
Conditions
Health Condition 1: null- ASA grade I or II patient, Non diabetic, Nonhypertensive and require catheterization
Registration Number
CTRI/2014/08/004934
Lead Sponsor
Apollo Hospitals Bilaspur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

1.ASA grade I and II,

2.Non hypertensive and non diabetic

3.Scheduled for surgery under general anesthesia requiring catheterization

Exclusion Criteria

1.patients with known sensitivity to study drugs,

2.history of drug or alcohol abuse,

3.history of chronic pain or daily intake of analgesics,

4.pregnant or breast-feeding females,

5.uncontrolled medical disease (diabetes mellitus and hypertension)

6.impaired kidney or liver functions and

7.psychiatric patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath